Efficacy and Safety of Indacaterol in Adults (40 Years and Above) With Chronic Obstructive Pulmonary Disease (COPD)
Status:
Completed
Trial end date:
2010-02-01
Target enrollment:
Participant gender:
Summary
This study evaluated the efficacy and safety of two doses of indacaterol in adults aged 40 or
over with chronic obstructive pulmonary disease (COPD) in China and in two other countries.